Cancer immunotherapy using γδT cells: dealing with diversity
The broad and potent tumour-reactivity of innate-like γδT cells makes them valuable additions to current cancer immunotherapeutic concepts based on adaptive immunity, such as monoclonal antibodies and αβT cells. Clinical success using γδT cells to treat cancer has so far fallen short however. Effort...
Main Authors: | Wouter eScheper, Zsolt eSebestyen, Jürgen eKuball |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00601/full |
Similar Items
-
Human γδ TCR Repertoires in Health and Disease
by: Alina Suzann Fichtner, et al.
Published: (2020-03-01) -
Comparing Mouse and Human Tissue-Resident γδ T Cells
by: Guanyu Qu, et al.
Published: (2022-06-01) -
A highly focused antigen receptor repertoire characterizes γδ T cells that are poised to make IL-17 rapidly in naive animals
by: Yu-Ling eWei, et al.
Published: (2015-03-01) -
T cell receptor signaling for γδT cell development
by: Ryunosuke Muro, et al.
Published: (2019-03-01) -
Expanded human blood-derived γδT cells display potent antigen-presentation functions
by: Mohd Wajid Ali Khan, et al.
Published: (2014-07-01)